Boston Professional Events List


Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy (C2)


Date
Mar 05, 2017 - 04:00 PM - Mar 08, 11:00 PM
Organizer
keystonesymposia
Location
Fairmont Copley Plaza, Boston, Massachusetts 02116,

Boston,
Massachusetts ,
US,
ZIP: 02116
Phone: +1 970-262-2690

Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy (C2)

Scientific Organizers: William A. Gahl and Christoph Klein

 

March 5—8, 2017

Fairmont Copley Plaza, Boston, Massachusetts, USA

 

Supported by Vertex Pharmaceuticals Incorporated

 
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

 
DEADLINES:
Scholarship Deadline: Nov 2, 2016 [details]
Discounted Abstract Deadline: Nov 2, 2016 [details]
Abstract Deadline: Dec 6, 2016 [details]
Discounted Registration Deadline: Jan 10, 2017 [details]

Click here to view Cancellation Policy

Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Vertex Pharmaceuticals Incorporated

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations
 

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations
 
 
If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: [email protected],
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: [email protected],
Phone:+1 970-262-2676


Agenda


The meeting will begin on Sunday, March 5 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, March 8 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Thursday, March 9 in order to fully experience the meeting.

SUNDAY, MARCH 5
 
16:00—20:00
Arrival and Registration
 
Lobby
 
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.
Venetian Room
 
MONDAY, MARCH 6
 
07:30—08:30
Breakfast
 
Venetian Room
 
08:30—09:30
Welcome and Keynote Address
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
Kym Boycott, CHEO Research Institute, Canada
Canada's Path Forward for Rare Diseases: Discovery to Translation
 
09:30—00:15
CRISPR/cas9; iPS; Embryonic Stem Cells
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
Speaker to be Announced
 
Coffee Break
 
Anne G. Bang, Sanford Burnham Prebys Medical Discovery Institute, USA
Phenotypic Screening of Human Induced Pluripotent Stem Cell (hiPSC) based Disease Models: Balancing throughput with Relevance
 
Josef M. Penninger, Institute of Molecular Biotechnology GmbH, Austria
Haploid Stem Cell Genetics
 
Short Talk(s) Chosen from Abstracts
 
00:15—17:00
On Own for Lunch
 
 
 
00:15—13:00
Poster Setup
 
Venetian Room
 
13:00—22:00
Poster Viewing
 
Venetian Room
 
14:30—16:30
Workshop
 
Oval Room
 
Short Talks Chosen from Abstracts
 
16:30—17:00
Coffee Available
 
Venetian Room
 
17:00—19:00
Mechanisms of Rare Disease
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
S. Celeste Morley, Washington University of St. Louis, USA
Plastin and Actin Defects
 
Christoph Klein, Ludwig-Maximilians-University Munich, Germany
Rare Genetic Variants Causing IBD: Lessons for Crohn’s Disease and Ulcerative Colitis
 
Scott Snapper, Harvard Medical School, USA
Immunological Mechanisms of Immune Tolerance in the Human Gut: Insights from Rare Diseases
 
Short Talk Chosen from Abstracts
 
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
Venetian Room
 
19:30—22:00
Poster Session 1
 
Venetian Room
 
TUESDAY, MARCH 7
 
07:30—08:30
Breakfast
 
Venetian Room
 
08:30—11:30
New Disease Discovery
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
William A. Gahl, NHGRI, National Institutes of Health, USA
The NIH Undiagnosed Diseases Program and Network
 
Craig D. Blackstone, National Institutes of Health, USA
Length Dependent Neuropathies and Membrane Transport Defects
 
Coffee Break
 
Hudson H. Freeze, Sanford Burnham Prebys Medical Discovery Institute, USA
Congenital Disorders of Glycosylation: Status and Perspectives
 
Jorge Di Paola, University of Colorado Anschutz Medical Campus, USA
Disorders of Platelets and von Willebrand Factor
 
Short Talk(s) Chosen from Abstracts
 
11:30—17:00
On Own for Lunch
 
 
 
11:30—13:00
Poster Setup
 
Venetian Room
 
13:00—22:00
Poster Viewing
 
Venetian Room
 
16:30—17:00
Coffee Available
 
Venetian Room
 
17:00—19:00
The Needs of Rare and Undiagnosed Disease Patients
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
Pat Furlong, Parent Project Muscular Dystrophy, USA
Talk Title to be Announced
 
Robin L. Smith†, NeoStem, USA
Talk Title to be Announced
 
Richard Moscicki, U.S. Food and Drug Administration, USA
The FDA Perspective on Rare Disease Therapeutics
 
Short Talk Chosen from Abstracts
 
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
Venetian Room
 
19:30—22:00
Poster Session 2
 
Venetian Room
 
WEDNESDAY, MARCH 8
 
07:30—08:30
Breakfast
 
Venetian Room
 
08:30—11:30
Therapeutics for Rare Diseases
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
Martin Andrews, GSK, UK
Meeting the Challenge of Rare Diseases
 
Kevin Strauss, Clinic for Special Children, USA
Talk Title to be Announced
 
Coffee Break
 
Omar Khwaja, F. Hoffmann-LaRoche AG, Switzerland
Clinical Development Opportunities in Rare Diseases
 
Rachel E. Meyers, Alnylam Pharmaceuticals Inc., USA
Therapeutic Applications of RNAi
 
Short Talk(s) Chosen from Abstracts
 
11:30—17:00
On Own for Lunch
 
 
 
16:30—17:00
Coffee Available
 
Venetian Room
 
17:00—06:45
Late-Breaking Discoveries and Technological Underpinnings of Rare and Undiagnosed Diseases Research
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
Speaker to be Announced
 
Speaker to be Announced
 
Speaker to be Announced
 
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/05/2017
 
Oval Room
 
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
Venetian Room
 
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
Venetian Room
 
THURSDAY, MARCH 9
 
 
Departure
 
 
 
*Session Chair †Invited, not yet responded.

Event Categories
Keywords: Book , communication , development , environment, industry , opportunities , opportunities, pharmaceutical , policy , scientist




Comments








Events Calendar

SunMonTueWedThuFriSat
26 27 28 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1

Tag Cloud

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99